Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04288609
Other study ID # Geha Mental Health Center
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 2020
Est. completion date December 1, 2020

Study information

Verified date February 2020
Source Geha Mental Health Center
Contact Gilad Eger, PhD
Phone +972523520180
Email giladeg1@clalit.org.il
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to test the efficacy of remedial cognitive intervention using The Functional Brain Trainer VR (FBT, Intendo ©) to improve cognitive functioning, participation in daily life occupations, and functional capacity in the field of IADL among people with affective disorders receiving inpatient and daycare mental-health services.


Description:

This study is an experimental study, in a pre-post design with a control group, the sampling is convenience. The study will include 40 people aged 18-60 with a diagnosis of Affective disorder based on DSM-5.

Inclusion criteria: age 18-60, Diagnosis of Major Depression or Bipolar disorder based on DSM-5; Mood stabilizing medication for at least 2 weeks, Exclusion criteria: Neurological disorders and neurodevelopmental conditions in addition to mental health diagnosis; Physical disability in addition to mental health conditions; Psychotic state; active substance abuse; custodian.

They will be recruited from active inpatient and daycare wards of the "Geha Mental Health Center", Israel and will be randomly allocated into two groups: experimental and control. An experimental group will attend 6 VR based cognitive remediation sessions of 30 minutes for training response inhibition, self-initiation, cognitive flexibility, sustained attention, divided attention, working memory, planning, persistence. The control group will complete 6 sessions of 30 minutes of low-tech (paper and pencil tasks) remedial training of the same cognitive components. These in addition to routine care. The evaluation for symptoms severity, cognition, functional capacity and participation in daily life activities will be conducted at the beginning of the study and after about 4 weeks.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date December 1, 2020
Est. primary completion date November 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Age 18-60,

- Diagnosis of Major Depression or Bipolar disorder based on DSM-5;

- Mood stabilizing medication for at least 2 weeks,

Exclusion Criteria:

- Neurological disorders and neuro-developmental conditions in addition to mental health diagnosis;

- Physical disability in addition to mental health conditions;

- Psychotic state;

- active substance abuse;

- custodian

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Intendu
Cognitive remediation using VR adaptive platform for response inhibition, self-initiation, cognitive flexibility, sustained attention, divided attention, working memory, planning, persistence.
Paper and Pencil cognitive remediation training
Cognitive remediation using paper and pencil tasks for response inhibition, self-initiation, cognitive flexibility, sustained attention, divided attention, working memory, planning, persistence.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Geha Mental Health Center Tel Aviv University

Outcome

Type Measure Description Time frame Safety issue
Primary The Observed Tasks of Daily Living - Revised Assessment of Functional capacity, score range 1 (dependent in the performance of daily life activities) up to 26 (fully independent in the performance of the daily life activities) 3 weeks
Primary Adults Subjective Assessment of Participation Questionnaire for assessment of participation in daily life activities: number of participated activities (from 1 to 52, the higher number indicates higher number of participated activities) and frequency of the participation (range from 1 indicates low frequency of participation up to 7 - higher frequency of the participation) 3 weeks
Secondary The Neurobehavioral Cognitive Status Examination Examination cognitive components of attention language, spatial skills, memory, calculations and reasoning. The score range for different sub-tests from 1 up to 4, 6, 8 or 12, with higher score indicates better cognitive functioning 3 weeks
Secondary Trail Making Test A & B Measure of cognitive flexibility and psycho-motor processing speed, the score is a time needed for the test completion, less time that needed indicates better cognitive functioning 3 weeks
Secondary Category Fluency Test Assessment of language fluency, the score is a number of produced words, the higher the number, the better cognitive fluency 3 weeks
Secondary Hamilton Depression Rating Scale Questionnaire Assessment of the depressive symptoms, the higher score indicates more severe depressive symptoms. 3 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04136054 - Better Sleep in Psychiatric Care - Anxiety and Affective Disorders N/A
Recruiting NCT05461885 - Value of Gym-based Exercise Training for Young Adults Receiving Antipsychotic Medication: The Vega Trial N/A
Completed NCT01721824 - The Effect of IPS-MA- A Modified Early Supported Employment Intervention for Individuals With Mood or Anxiety Disorders N/A
Recruiting NCT05869409 - Physical Activity, Psychopathology, and Quality of Life in People With Psychotic or Affective Disorders
Active, not recruiting NCT05249309 - Naturalistic Study of Ketamine in the Treatment of Depression
Completed NCT03235908 - Copeptin in Outcome Prediction of an Acute Psychotic Episode
Recruiting NCT03294525 - Towards Neurobiology-based Diagnosis and Treatment of Affective Disorders
Completed NCT04489641 - Brief Group Psychotherapy for Anxiety and Depression N/A
Recruiting NCT05596461 - New Techniques for Diagnosis and Treatment of Cognitive Impairment in Affective Disorder N/A
Completed NCT03609515 - Patient-controlled Admissions in Inpatient Mental Health Services N/A